METROPOLIS HEALTHCARE
|
|
BOM : 542650     NSE : METROPOLIS     | |
LT :  
    Long Term Analysis
Fundamentals : Good
Valuation : Average [Stock is fairly valued] Debt : Low |
Updated: |
ST :  
    Short Term Analysis
Quarterly Earnings Trend : Upward
Price Momentum : Mild Upward Pledged Shares : None or < 25% |
Aug 30,2024 |
Price(EOD): ₹ 2,139.75
This is the End-of-Day (EOD) Stock Price updated daily by 7 pm IST.
|
Hospital & Healthcare Services |
MCap: ₹ 10,955.52 Cr |
Industry Peers & Returns | 1W | 1M | 1Y |
METROPOLIS HEALTHCARE | 1.8% | 1.2% | 57.3% |
APOLLO HOSPITALS ENTERPRISE | 2.2% | 4.6% | 41.1% |
MAX HEALTHCARE INSTITUTE | 0.4% | -6.3% | 56.4% |
GLOBAL HEALTH | 7.1% | -8.6% | 59.6% |
FORTIS HEALTHCARE | 2% | 10% | 61.6% |
NARAYANA HRUDAYALAYA | -0.8% | 1% | 22% |
FUNDAMENTAL ANALYSIS OF METROPOLIS HEALTHCARE
 Y : Last Audited Annual/Yearly Data
TTM i.e. Trailing Twelve Months is calculated using last 4 quarterly data and is a good substitute to track last 4 Qtr Annual result before the subsequent year data is published and audited.
Learn More
VALUATION OF METROPOLIS HEALTHCARE
 Ratio | Consolidated | |
---|---|---|
P/E P/B P/S |
79.69
P/E Calculated based on Trailing Twelve Months (TTM) Earnings of Rs 137.59 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] 10.07
P/B Calculated based on Book Value of Rs 1,088.43 Cr
[Latest Year - Mar2024 - Consolidated Results ] 8.81
P/S Calculated based on Trailing Twelve Months (TTM) Revenues of Rs 1,243.97 Cr
[Latest Qtr - Jun2024 - Consolidated Results ] |
|
Financial Ratios → |
Model | Discount(-)/ Premium(+) |
---|---|
EV/EBIDTA EV/Sales Price/Sales |
26% 18% 8% |
SHARE PRICE MOMENTUM OF METROPOLIS HEALTHCARE
METROPOLIS HEALTHCARE vs SENSEX
DEBT OF METROPOLIS HEALTHCARE
Year | Debt/Equity ratio | |
---|---|---|
Standalone | Consolidated | |
2024 2023 2022 Avg_3yrs |
0 0.09 0.31 0.13 |
0 0.08 0.3 0.13 |
[Last Annual Data : Mar2024]
|
||
Financial Ratios → |
PLEDGED PROMOTER SHARES OF METROPOLIS HEALTHCARE
Pledged Promoter Shares |
1.18 % | |
---|---|---|
As on : Dec2023 | ||
If less than 25% | Good |
|
If between 25% and 50% | Neutral | |
If greater than 50% | Bad | |
Shareholding Pattern → |
QTRLY RESULTS OF METROPOLIS HEALTHCARE
Consolidated | Q-o-Q | Y-o-Y |
---|---|---|
Revenue Op Profit Profit Before Tax Profit After Tax |
-5.33% -1.46% 1.08% 4.34% |
13.09% 25.22% 30.33% 31.5% |
QtrlyTrend |
4 | |
Latest Qtr: Jun2024 | ||
Quarterly Result Analysis → |
METROPOLIS HEALTHCARE related INDICES
BSE Indices | 1W | 1M | 1Y |
---|---|---|---|
S&P BSE HEALTHCARE | 2.5% | 7.5% | 54.8% |
S&P BSE 500 | 1.3% | 1.2% | 39.5% |
S&P BSE ALLCAP | 1.2% | 1.2% | 40.7% |
S&P BSE 250 SMALLCAP | 1.1% | 1.2% | 53% |
S&P BSE 400 MIDSMALLCAP | 1.1% | 0.9% | 53.3% |
NSE Indices | 1W | 1M | 1Y |
---|---|---|---|
NIFTY HEALTHCARE | 2.9% | 6.5% | 52% |
NIFTY 500 | 1.4% | 1.3% | 40.2% |
NIFTY500 MULTICAP 50:25:25 | 1.3% | 1.2% | 44.8% |
NIFTY MID SMALL400 | 1.2% | 0.9% | 52.9% |
NIFTY SMALLCAP250 | 0.9% | 1% | 57% |
You may also like the below Video Courses
FAQ about METROPOLIS HEALTHCARE
Is METROPOLIS HEALTHCARE good for long term investment?
As on Aug 30,2024, the Fundamentals of METROPOLIS HEALTHCARE look Strong and hence it may be good for long term investment! See Financial Performance of METROPOLIS HEALTHCARE . Please look at the other parameters such as Valuation, Price Momentum, News & Corporate Governance and/or consult an Investment Advisor before taking an investment decision!Is METROPOLIS HEALTHCARE UnderValued or OverValued?
As on Aug 30,2024, METROPOLIS HEALTHCARE is Fairly Valued based on the estimates of intrinsic value and investors may wait for the buying opportunity once it becomes under valued!What is the Intrinsic Value of METROPOLIS HEALTHCARE ?
As on Aug 30,2024, the Intrinsic Value of METROPOLIS HEALTHCARE is Rs. 1,812.78 estimated based on Median of the 3 historical models.Fair Value [Median EV / EBIDTA Model] : Rs. 1,697.15
Fair Value [Median EV / Sales Model] : Rs. 1,812.78
Fair Value [Median Price / Sales Model] : Rs. 1,976.99
Estimated Median Fair Value of METROPOLIS HEALTHCARE : Rs. 1,812.78
The fair value of any stock is always subjective and should, in no way, be taken as a recommendation to buy/sell the same.